Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Dopatka

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Clinical Laboratory Analysis|January 1, 1992
Single point quantification of antibody by ELISA without need of a reference curveH D Dopatka, B Giesendorf
Research in Virology|January 1, 1996
Compact Epstein-Barr virus diagnosis based on a defined antigen mix and specific IgAH D Dopatka, W Schuy
La Ricerca in Clinica E in Laboratorio|January 1, 1983
[Hepatitis non-A, non-B diagnosis-by-exclusion]H D Dopatka, F Behrens
Molecular & General Genetics : MGG|January 24, 1973
Amber mutants of Salmonella-phage P22 in genes engaged in the establishment of lysogenyH D Dopatka, H H Prell
Infection|July 1, 1994
Multicenter evaluation of a novel quantification method for rubella and toxoplasmosis antibodiesB Martens-Düring, H D Dopatka
European Journal of Cancer|February 1, 1978
BCG-immunotherapy of L2C-guinea pig leukemiaH D Dopatka, M Majer, H Freudenstein
Molecular & General Genetics : MGG|December 31, 1973
Functional classification of P22 amber mutantsW Bode, H D Dopatka, H H Prell
Developments in Biological Standardization|April 13, 1977
BCG-immunotherapy of L2C guinea pig leukemiaH D Dopatka, M Majer, H Freudenstein, et al.
Developments in Biological Standardization|April 13, 1977
Interference of preceding BCG vaccination with BCG immunotherapy in L2C-guinea pig leukemiaH D Dopatka, M Majer, W Hennessen, et al.
Medical Microbiology and Immunology|January 1, 1989
Technical improvements of a commercial ELISA to detect antibodies against bovine herpesvirus 1K H Witte, P Hannemann, H D Dopatka, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Clinical Laboratory Analysis|January 1, 1992
Single point quantification of antibody by ELISA without need of a reference curveH D Dopatka, B Giesendorf
Research in Virology|January 1, 1996
Compact Epstein-Barr virus diagnosis based on a defined antigen mix and specific IgAH D Dopatka, W Schuy
La Ricerca in Clinica E in Laboratorio|January 1, 1983
[Hepatitis non-A, non-B diagnosis-by-exclusion]H D Dopatka, F Behrens
Molecular & General Genetics : MGG|January 24, 1973
Amber mutants of Salmonella-phage P22 in genes engaged in the establishment of lysogenyH D Dopatka, H H Prell
Infection|July 1, 1994
Multicenter evaluation of a novel quantification method for rubella and toxoplasmosis antibodiesB Martens-Düring, H D Dopatka
European Journal of Cancer|February 1, 1978
BCG-immunotherapy of L2C-guinea pig leukemiaH D Dopatka, M Majer, H Freudenstein
Molecular & General Genetics : MGG|December 31, 1973
Functional classification of P22 amber mutantsW Bode, H D Dopatka, H H Prell
Developments in Biological Standardization|April 13, 1977
BCG-immunotherapy of L2C guinea pig leukemiaH D Dopatka, M Majer, H Freudenstein, et al.
Developments in Biological Standardization|April 13, 1977
Interference of preceding BCG vaccination with BCG immunotherapy in L2C-guinea pig leukemiaH D Dopatka, M Majer, W Hennessen, et al.
Medical Microbiology and Immunology|January 1, 1989
Technical improvements of a commercial ELISA to detect antibodies against bovine herpesvirus 1K H Witte, P Hannemann, H D Dopatka, et al.
Pageof 2